Evidence map›Paper›PMID 41974653›Full record

ArticleCell death discovery2026

Dual control of liver regeneration by Nr1d1 homeostasis and Klf2 checkpoint.

Bingyu Ye, Dejian Xie, Wenlong Shen, Meijuan Yue, Qinpeng Jin, Xinjie Guo, Yan Zhang, Ping Li, Zhihu Zhao

Abstract read
In one paragraph

Article in Cell death discovery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Bingyu Ye *Laboratory of Advanced Biotechnology, Beijing Institute of Biotechnology, Beijing, China.ORCID http://orcid.org/0000-0001-6772-5063
Dejian Xie *Laboratory of Advanced Biotechnology, Beijing Institute of Biotechnology, Beijing, China.
Wenlong Shen *Laboratory of Advanced Biotechnology, Beijing Institute of Biotechnology, Beijing, China.ORCID http://orcid.org/0000-0002-2293-5590
Meijuan YueState Key Laboratory of Cell Differentiation and Regulation, College of Life Sciences, Henan Normal University, Xinxiang, China.
Qinpeng JinLaboratory of Advanced Biotechnology, Beijing Institute of Biotechnology, Beijing, China.
Xinjie GuoLaboratory of Advanced Biotechnology, Beijing Institute of Biotechnology, Beijing, China.
Yan ZhangLaboratory of Advanced Biotechnology, Beijing Institute of Biotechnology, Beijing, China. zany1983@163.com.ORCID http://orcid.org/0000-0003-4006-663X
Ping LiLaboratory of Advanced Biotechnology, Beijing Institute of Biotechnology, Beijing, China. lipingtry@163.com.ORCID http://orcid.org/0000-0003-1872-1546
Zhihu ZhaoLaboratory of Advanced Biotechnology, Beijing Institute of Biotechnology, Beijing, China. zhaozh@bmi.ac.cn.ORCID http://orcid.org/0000-0001-7081-8914

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Following extensive liver resections, diminished liver regeneration impairs the maintenance or restoration of sufficient functional liver mass. Currently, effective therapies to restore liver regeneration are lacking, rendering liver transplantation the sole treatment option for end-stage liver disease. Therefore, it is imperative to elucidate the regulatory mechanisms underlying liver regeneration. In this study, we employed a multi-omics approach integrating Hi-C, RNA-seq, and ATAC-seq to dissect the early regulatory mechanisms of liver regeneration in rats and mice. Our results indicate that immune and inflammatory processes are markedly enriched during the early phase of regeneration, accompanied by upregulation of glucocorticoids (GCs) and their receptor (GR). First, the expression dynamics of the GC-related circadian gene Nr1d1 and its regulatory network-including Nfκbiα, Arntl, Clock, and Rora-align with chromatin reorganization, leading us to propose that the GC-GR-Nr1d1 axis is involved in maintaining liver homeostasis. Second, the GR-regulated FoxO family is significantly enriched, and the FoxO-associated gene Klf2 exhibits coordinated changes in expression, chromatin accessibility, and chromatin structure. Functional experiments demonstrate that Klf2 negatively regulates hepatocyte proliferation. Hence, we propose the GC-GR-FoxOs-Klf2 axis acts as a checkpoint in hepatocyte proliferation, preventing premature activation of proliferation- and cell cycle-related genes and ensuring orderly and efficient liver regeneration. Our findings on the role of GCs in liver regeneration may further support their future therapeutic application in liver diseases such as liver fibrosis, alcoholic cirrhosis, and hepatocellular carcinoma (HCC).

Identifiers

PMID41974653
PMCPMC13183961

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.